Literature DB >> 9114406

Evaluation of monoclonal antibodies for subtyping of currently circulating human type A influenza viruses.

M Tkácová1, E Varecková, I C Baker, J M Love, T Ziegler.   

Abstract

The hemagglutinin subtype specificities of six monoclonal antibodies (MAbs) to influenza type A viruses were evaluated in a rapid culture assay by immunoperoxidase staining. Confluent monolayers of MDCK cells in multiwell plates were inoculated with (i) 23 reference viruses, (ii) 200 isolates collected during the influenza season 1995 to 1996, and (iii) 28 clinical specimens previously found to be influenza virus positive. After overnight incubation, the cells were fixed and stained with MAbs IVA1/B10, IIF4/D3, 12L/5, 13L/6, 18L/1, or 18L/4. Type-specific MAbs were included as controls. All antibodies gave intensive cytoplasmic staining with infected cells in the absence of any reaction with uninfected cells. MAbs 12L/5, 13L/6, 18L/1, and 18L/4 exclusively reacted with viruses of the subtype H1, and the antibodies IVA1/B10 and IIF4/D3 exclusively reacted with viruses of the subtype H3. None of these MAbs reacted with viruses of the H2 subtype or with influenza type B viruses. Of the 200 recent isolates, 63 were identified as influenza virus type A, subtype H1, 95 were identified as type A, subtype H3, and 41 were identified as type B. One isolate contained a mixture of a type A (H3) and a type B influenza virus. Of the 28 previously positive clinical specimens, 15 contained an influenza virus A, subtype H3, 1 contained an influenza virus A, subtype H1, and 9 contained an influenza B virus. The subtype of a very weakly positive specimen could not be determined, and two specimens remained negative. The MAbs described here allow for a rapid typing and subtyping of influenza virus isolates and for the type- and subtype-specific detection of influenza viruses in clinical specimens.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9114406      PMCID: PMC232728          DOI: 10.1128/jcm.35.5.1196-1198.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  10 in total

1.  Rapid detection of respiratory syncytial virus and influenza A virus in cell cultures by immunoperoxidase staining with monoclonal antibodies.

Authors:  M Waris; T Ziegler; M Kivivirta; O Ruuskanen
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

2.  Changes in the influenza virus haemagglutinin at acid pH detected by monoclonal antibodies to glycopolypeptides HA1 and HA2.

Authors:  F Kostolansky; G Russ; V Mucha; B Styk
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

3.  Isolation of cross-reactive, subtype-specific monoclonal antibodies against influenza virus HA1 and HA2 hemagglutinin subunits.

Authors:  A Sánchez-Fauquier; N Villanueva; J A Melero
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

4.  Influenza: global surveillance for epidemic and pandemic variants.

Authors:  N J Cox; T L Brammer; H L Regnery
Journal:  Eur J Epidemiol       Date:  1994-08       Impact factor: 8.082

5.  Type- and subtype-specific detection of influenza viruses in clinical specimens by rapid culture assay.

Authors:  T Ziegler; H Hall; A Sánchez-Fauquier; W C Gamble; N J Cox
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

6.  Preparation of monoclonal antibodies for the diagnosis of influenza A infection using different immunization protocols.

Authors:  E Varecková; T Betáková; V Mucha; L Soláriková; F Kostolanský; M Waris; G Russ
Journal:  J Immunol Methods       Date:  1995-03-13       Impact factor: 2.303

7.  Characterization and evaluation of monoclonal antibodies developed for typing influenza A and influenza B viruses.

Authors:  H H Walls; M W Harmon; J J Slagle; C Stocksdale; A P Kendal
Journal:  J Clin Microbiol       Date:  1986-02       Impact factor: 5.948

8.  Comparison of rapid detection methods for influenza A virus and their value in health-care management of institutionalized geriatric patients.

Authors:  G P Leonardi; H Leib; G S Birkhead; C Smith; P Costello; W Conron
Journal:  J Clin Microbiol       Date:  1994-01       Impact factor: 5.948

9.  Monoclonal antibodies to glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin.

Authors:  G Russ; K Poláková; F Kostolanský; B Styk; M Vancíková
Journal:  Acta Virol       Date:  1987-09       Impact factor: 1.162

10.  Monoclonal antibodies for rapid, strain-specific identification of influenza virus isolates.

Authors:  N J Schmidt; M Ota; D Gallo; V L Fox
Journal:  J Clin Microbiol       Date:  1982-10       Impact factor: 5.948

  10 in total
  9 in total

1.  Evaluation of the subtype specificity of monoclonal antibodies raised against H1 and H3 subtypes of human influenza A virus hemagglutinins.

Authors:  Eva Varecková; Nancy Cox; Alexander Klimov
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

2.  Subtyping influenza A virus with monoclonal antibodies and an indirect immunofluorescence assay.

Authors:  Jennifer Johnson; Angela Higgins; Adriana Navarro; Yung Huang; Frank L Esper; Nicole Barton; Derek Esch; Carl Shaw; Paul D Olivo; Lynn Yihong Miao
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

3.  Application of subtype-specific monoclonal antibodies for rapid detection and identification of influenza A and B viruses.

Authors:  M Ueda; A Maeda; N Nakagawa; T Kase; R Kubota; H Takakura; A Ohshima; Y Okuno
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

4.  Monoclonal antibody kit for identification of the novel 2009 H1N1 influenza A virus.

Authors:  Angela D Higgins; Carl J Shaw; Jennifer G Johnson; Adriana Navarro; Nathan A Chapman; Steven D Ewers; James W Stockwell; Julie M Carpenter; Paul D Olivo; Lynn Yihong Miao
Journal:  J Clin Microbiol       Date:  2010-06-02       Impact factor: 5.948

5.  Construction and characterization of insect cell-derived influenza VLP: cell binding, fusion, and EGFP incorporation.

Authors:  Yi-Shin Pan; Hung-Ju Wei; Chung-Chieh Chang; Chung-Hung Lin; Ting-Shyang Wei; Suh-Chin Wu; Ding-Kwo Chang
Journal:  J Biomed Biotechnol       Date:  2010-12-09

6.  Targets for the induction of protective immunity against influenza a viruses.

Authors:  Rogier Bodewes; Albert D M E Osterhaus; Guus F Rimmelzwaan
Journal:  Viruses       Date:  2010-01-14       Impact factor: 5.818

7.  Biological properties of influenza A virus mutants with amino acid substitutions in the HA2 glycoprotein of the HA1/HA2 interaction region.

Authors:  L Jakubcová; M Vozárová; J Hollý; K Tomčíková; M Fogelová; K Polčicová; F Kostolanský; E Fodor; E Varečková
Journal:  J Gen Virol       Date:  2019-09       Impact factor: 3.891

Review 8.  Laboratory diagnosis of human seasonal and pandemic influenza virus infection.

Authors:  Dominic E Dwyer; David W Smith; Michael G Catton; Ian G Barr
Journal:  Med J Aust       Date:  2006-11-20       Impact factor: 7.738

9.  Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses.

Authors:  Reiko Yoshida; Manabu Igarashi; Hiroichi Ozaki; Noriko Kishida; Daisuke Tomabechi; Hiroshi Kida; Kimihito Ito; Ayato Takada
Journal:  PLoS Pathog       Date:  2009-03-20       Impact factor: 6.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.